Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 4/20 | 0.94 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.50 |
| ▸ | TYR | P14679 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.50 |
| ▸ | ALDH5A1 | P51649 | 1/20 | 0.50 |
| ▸ | ABAT | P80404 | 1/20 | 0.50 |
| ▸ | CYP2A13 | Q16696 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 1/20 | 0.48 |
| ▸ | RAB9A | P51151 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | ACHE | P22303 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | ALDH1A3 | P47895 | 2/20 | 0.46 |
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.46 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.44 |
| ▸ | FBP1 | P09467 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29171 | 0.97 | — | — | |
| SCHEMBL8469408 | 0.97 | CYP2A6 (1.00) | CYP2A6ALDH1A1TYRHSD17B10ALDH5A1 | |
| P-Xylene SCHEMBL10939332 | 0.97 | CYP2A6 (1.00) | CYP2A6ALDH1A1TYRHSD17B10ALDH5A1 | |
| SCHEMBL28981619 | 0.94 | CYP2A6 (0.94) | CYP2A6ALDH1A1TYRHSD17B10ALDH5A1 | |
| Iodide SCHEMBL34461933 | 0.94 | CYP2A6 (0.94) | CYP2A6ALDH1A1TYRHSD17B10ALDH5A1 | |
| SCHEMBL28788188 | 0.94 | — | — | |
| SCHEMBL585055 | 0.94 | CYP2A6 (0.94) | CYP2A6ALDH1A1TYRHSD17B10ALDH5A1 | |
| Hydrochloric Acid SCHEMBL14686576 | 0.94 | CYP2A6 (0.94) | CYP2A6ALDH1A1TYRHSD17B10ALDH5A1 | |
| SCHEMBL586330 | 0.94 | CYP2A6 (0.94) | CYP2A6ALDH1A1TYRHSD17B10ALDH5A1 | |
| Water SCHEMBL28202451 | 0.94 | CYP2A6 (0.94) | CYP2A6ALDH1A1TYRHSD17B10ALDH5A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8119749-B2 | Method of taking (meth)acrylic ester polymer out of liquid reaction mixture | KURARAY CO., LTD. (JP) | 2012-02-21 | — | — | US | disclosed |
| EP-1916262-B1 | METHOD OF TAKING (METH)ACRYLIC ESTER POLYMER OUT OF LIQUID REACTION MIXTURE | KURARAY CO (JP) | 2012-02-15 | — | — | EP | disclosed |
| US-7973117-B2 | Milder temperatures, higher speed; controlled molecular weight and narrow distribution thermoplastic elastomers | KURARAY CO., LTD. (JP) | 2011-07-05 | — | — | US | disclosed |
| US-20090118450-A1 | METHOD OF TAKING (METH)ACRYLIC ESTER POLYMER OUT OF LIQUID REACTION MIXTURE | KURARAY CO., LTD. (JP) | 2009-05-07 | — | — | US | disclosed |
| EP-1780222-B1 | PROCESS FOR CONTINUOUSLY PRODUCING (METH)ACRYLIC ESTER POLYMER OR COPOLYMER | KURARAY CO (JP) | 2008-11-26 | — | — | EP | disclosed |
| US-20080139759-A1 | Process For Continuously Producing (Meth)Acrylic Ester Polymer or Copolymer | KURARAY CO., LTD. (JP) | 2008-06-12 | — | — | US | disclosed |
| EP-1916262-A1 | METHOD OF TAKING (METH)ACRYLIC ESTER POLYMER OUT OF LIQUID REACTION MIXTURE | Kuraray Co., Ltd. (JP) | 2008-04-30 | — | — | EP | disclosed |
| EP-1780222-A1 | PROCESS FOR CONTINUOUSLY PRODUCING (METH)ACRYLIC ESTER POLYMER OR COPOLYMER | KURARAY CO., LTD. (JP) | 2007-05-02 | — | — | EP | disclosed |
| EP-0523100-B1 | O6 -BENZYLATED GUANINE, GUANOSINE AND 2'-DEOXYGUANOSINE COMPOUNDS POSSESSING O6 -ALKYLGUANINE-DNA ALKYLTRANSFERASE DEPLETING ACTIVITY | US HEALTH (US) | 1996-08-28 | — | — | EP | disclosed |
| US-5358952-A | Anticarcinogenic agents | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1994-10-25 | — | — | US | disclosed |
| US-5352669-A | Increases host responsiveness to anti-neoplastic alkylating agents including chloroethylating agents for chemotheraputical treatment | THE OF THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1994-10-04 | — | — | US | disclosed |
| EP-0523100-A4 | O?6 -BENZYLATED GUANINE, GUANOSINE AND 2'-DEOXYGUANOSINE COMPOUNDS POSSESSING O?6 -ALKYLGUANINE-DNA ALKYLTRANSFERASE DEPLETING ACTIVITY | US HEALTH (US) | 1993-03-17 | — | — | EP | disclosed |
| EP-0523100-A1 | O?6 -BENZYLATED GUANINE, GUANOSINE AND 2'-DEOXYGUANOSINE COMPOUNDS POSSESSING O?6 -ALKYLGUANINE-DNA ALKYLTRANSFERASE DEPLETING ACTIVITY. | US HEALTH (US) | 1993-01-20 | — | — | EP | disclosed |
| US-5091430-A | Increase response to antitumor agents | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 1992-02-25 | — | — | US | disclosed |
| WO-1991013898-A1 | O6-BENZYLATED GUANINE, GUANOSINE AND 2'-DEOXYGUANOSINE COMPOUNDS POSSESSING O6-ALKYLGUANINE-DNA ALKYLTRANSFERASE DEPLETING ACTIVITY | THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, UNITED STATES DEPARTMENT OF COMMERCE (US) | 1991-09-19 | — | — | WO | disclosed |